A Randomized, Double-blinded, Placebo-controlled Trial of Sitagliptin for Reducing Inflammation and Immune Activation in Treated and Suppressed Human Immunodeficiency Virus Infection
published in: Clinical Infectious Diseases
date of publication: 2019-09-01
main subject: placebo, placebo-controlled trial
Cites articles 33
- 2012-06-28
Date
Title
Article - wd:Q90391290